Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Methoxy polyethylene glycol-epoetin beta
CAS 677324-53-7
Concern score
Not assessed — no hazard data yet.
Why it's flagged
FDA NDC lists this ingredient in 9 active drug products and 9 total products.
Regulation
No restrictions found. Methoxy polyethylene glycol-epoetin beta appears in these published regulatory listings.
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- ingredient_type:ingredient substance
- marketed_drug_ingredient
- nsde_reference_present
- substance_class:protein
- substance_type:protein
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 9 active drug products and 9 total products.
- FDA NDC lists this ingredient in 9 active drug products and 9 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as protein.
- openFDA substance registry classifies this ingredient as protein.Source →
Evidence
No graded sources yet for Methoxy polyethylene glycol-epoetin beta. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Methoxy polyethylene glycol-epoetin beta in our catalog (fda_ndc).
Products
9
